1. HBW Insight
  2. >>Wellness
  3. >>Policy & Regulation
  4. >>Legal

FTC’s Health Products Guidance: Attorneys Discuss Insistence On RCTs, Implications For Businesses

 
• By Eileen Francis

The updated and expanded guidance embodies the US Federal Trade Commission’s enforcement approach for more than a decade, identifying randomized clinical trials as the competent and reliable scientific evidence needed to back health-related claims. Attorneys from Kelley Drye & Warren, Lathrop GMP and Amin Talati Wasserman weigh in.

FTC Legal Gavel Concept 3D Illustration

The US Federal Trade Commission’s Health Products Compliance Guidance is a “sweeping overhaul” of its predecessor and a continuation of the agency’s decade-long march toward a drug-like substantiation standard for non-drug product claims, says John Villafranco, a partner at Kelley Drye & Warren, LLP.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal

More from Policy & Regulation